Stock Updates: Cyclo Therapeutics, Lucy Scientific, Pasithea Therapeutics and Apple Making Waves
- June 05th, 2023
- 268 views
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) has entered into a binding agreement with Rafael Holdings, Inc. (NYSE: RFL).
Under the agreement, Rafael will acquire 4,000,000 shares of CYTH's common stock, along with warrants to purchase an additional 4,000,000 shares, for a total purchase price of $5,000,000.
$CYTH is currently trading at $1.42, reflecting a slight increase of $0.01 (+0.71%).
In other news, Lucy Scientific Discovery Inc. (Nasdaq: LSDI) has made a proposal to acquire Pasithea Therapeutics Corp. (Nasdaq: KTTA) through a cash-and-stock transaction.
The proposal suggests a per-share acquisition price of $0.85, comprising $0.60 in cash and $0.25 in Lucy stock.
Trading for both $LSDI and $KTTA has been halted in light of this development.
Additionally, BofA Securities has raised the price target for Apple Inc. (Nasdaq: AAPL) from $176 to $190, while Evercore ISI Group increased it from $190 to $210.
Currently, $AAPL is trading at $183.58, reflecting a positive movement of $2.63 (+1.45%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login